Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Impact of the gut microbiota on enhancer accessibility in gut intraepithelial lymphocytes.

Semenkovich NP, Planer JD, Ahern PP, Griffin NW, Lin CY, Gordon JI.

Proc Natl Acad Sci U S A. 2016 Dec 20;113(51):14805-14810. doi: 10.1073/pnas.1617793113. Epub 2016 Dec 1.

2.

Development of the gut microbiota and mucosal IgA responses in twins and gnotobiotic mice.

Planer JD, Peng Y, Kau AL, Blanton LV, Ndao IM, Tarr PI, Warner BB, Gordon JI.

Nature. 2016 Jun 9;534(7606):263-6. doi: 10.1038/nature17940. Epub 2016 May 25.

3.

Characterizing the interactions between a naturally primed immunoglobulin A and its conserved Bacteroides thetaiotaomicron species-specific epitope in gnotobiotic mice.

Peterson DA, Planer JD, Guruge JL, Xue L, Downey-Virgin W, Goodman AL, Seedorf H, Gordon JI.

J Biol Chem. 2015 May 15;290(20):12630-49. doi: 10.1074/jbc.M114.633800. Epub 2015 Mar 20.

4.

Functional characterization of IgA-targeted bacterial taxa from undernourished Malawian children that produce diet-dependent enteropathy.

Kau AL, Planer JD, Liu J, Rao S, Yatsunenko T, Trehan I, Manary MJ, Liu TC, Stappenbeck TS, Maleta KM, Ashorn P, Dewey KG, Houpt ER, Hsieh CS, Gordon JI.

Sci Transl Med. 2015 Feb 25;7(276):276ra24. doi: 10.1126/scitranslmed.aaa4877.

5.

Synergy testing of FDA-approved drugs identifies potent drug combinations against Trypanosoma cruzi.

Planer JD, Hulverson MA, Arif JA, Ranade RM, Don R, Buckner FS.

PLoS Negl Trop Dis. 2014 Jul 17;8(7):e2977. doi: 10.1371/journal.pntd.0002977. eCollection 2014 Jul.

6.

Dialkylimidazole inhibitors of Trypanosoma cruzi sterol 14α-demethylase as anti-Chagas disease agents.

Suryadevara PK, Racherla KK, Olepu S, Norcross NR, Tatipaka HB, Arif JA, Planer JD, Lepesheva GI, Verlinde CL, Buckner FS, Gelb MH.

Bioorg Med Chem Lett. 2013 Dec 1;23(23):6492-9. doi: 10.1016/j.bmcl.2013.08.015. Epub 2013 Aug 12.

Supplemental Content

Loading ...
Support Center